CPOAX
Price
$45.76
Change
-$0.22 (-0.48%)
Updated
Jun 16 closing price
Net Assets
1.23B
RGACX
Price
$83.91
Change
-$0.76 (-0.90%)
Updated
Jun 16 closing price
Net Assets
360.63B
Interact to see
Advertisement

CPOAX vs RGACX

Header iconCPOAX vs RGACX Comparison
Open Charts CPOAX vs RGACXBanner chart's image
CPOAX vs RGACX Comparison Chart in %
View a ticker or compare two or three
VS
CPOAX vs. RGACX commentary
Jun 18, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CPOAX is a Hold and RGACX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGACX has more cash in the bank: 361B vs. CPOAX (1.23B). CPOAX (0.00) and RGACX (0.00) have matching dividends . CPOAX was incepted earlier than RGACX: CPOAX (29 years) vs RGACX (24 years). CPOAX (1.16) is less costly to investors than RGACX (0.93). CPOAX is a more actively managed with annual turnover of: 48.00 vs. RGACX (32.00). RGACX has a lower initial minimum investment than CPOAX: RGACX (250) vs CPOAX (1000). RGACX annual gain was more profitable for investors over the last year : 9.90 vs. CPOAX (7.81). RGACX return over 5 years is better than : 17.49 vs. CPOAX (-46.55).
CPOAXRGACXCPOAX / RGACX
Total Expense Ratio1.160.93125%
Annual Report Gross Expense Ratio1.160.93125%
Fund Existence29 years24 years-
Gain YTD0.7018.3418%
Front Load5%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.23B361B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year7.819.9079%
Returns for 3 years99.5144.13225%
Returns for 5 years-46.5517.49-266%
Returns for 10 years54.66108.2550%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GGHYX39.63N/A
N/A
Invesco Health Care Y
MSEQX67.12N/A
N/A
Morgan Stanley Inst Growth I
VHCOX119.61N/A
N/A
Vanguard Capital Opportunity Inv
ETCEX17.12N/A
N/A
Eventide Exponential Technologies C
DVLIX32.71-0.14
-0.43%
BNY Mellon Midcap Value Fund I